1. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis
   Shenghua Dong et al, 2020, Molecular Genetics & Genomic Medicine CrossRef
2. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
   Maria Konoshenko et al, 2022, International Journal of Molecular Sciences CrossRef
3. TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma
   Ke Zhang et al, 2020, Cancer Cell International CrossRef
4. Arylcoumarin and novel biscoumarin derivatives as potent inhibitors of human glutathione S-transferase
   Lalehan Ozalp et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
5. Glutathione S-Transferases in Cancer
   Rahul Raj Singh et al, 2021, Antioxidants CrossRef
6. miRNA Regulation of Glutathione Homeostasis in Cancer Initiation, Progression and Therapy Resistance
   Barbara Marengo et al, 2020, MicroRNA CrossRef
7. MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological and Pathological Responses
   Yongjie Xu et al, 2021, MicroRNA CrossRef
8. MicroRNAs involved in drug resistance of breast cancer by regulating autophagy
   Nan Wen et al, 2020, Journal of Zhejiang University-SCIENCE B CrossRef
9. Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
   Priya Mondal et al, 2023, Frontiers in Pharmacology CrossRef
10. miR‑4486 reverses cisplatin‑resistance of colon cancer cells via targeting ATG7 to inhibiting autophagy
    Weiwei Wang et al, 2021, Experimental and Therapeutic Medicine CrossRef
11. MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer
    Sha Xiao et al, 2018, Molecular Genetics and Genomics CrossRef
12. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
    Morana Jaganjac et al, 2020, Antioxidants CrossRef
13. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance
    Xinyi Zhang et al, 2020, Molecular Cancer CrossRef
14. Glutathione S-Transferases S1, Z1 and A1 Serve as Prognostic Factors in Glioblastoma and Promote Drug Resistance through Antioxidant Pathways
    Bo Cheng et al, 2022, Cells CrossRef
15. Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer
    Haixiang Yu et al, 2019, Canadian Respiratory Journal CrossRef
16. Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature—A New Goal for Early Diagnosis and Therapy?
    Filippo Ricciardiello et al, 2021, Journal of Clinical Medicine CrossRef
17. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
    Pía Loren et al, 2022, Frontiers in Pharmacology CrossRef